Pagerduty earnings beat by $0.05, revenue topped estimates

Pagerduty (PD) reported Q1 EPS of $0.24, exceeding estimates by $0.05, with revenue slightly above consensus at $119.8M. However, the company's Q2 and FY2026 EPS guidance of $0.19-$0.20 and $0.95-$1.00 respectively, surpassed analyst expectations, while revenue guidance of $122.50M-$124.50M and $493.00M-$499.00M respectively, fell short of consensus estimates. Despite the EPS beat, the stock has declined -9.14% over the last 3 months and -10.31% over the last 12 months amid mixed EPS revisions and a "fair performance" financial health score.

Analysis

Pagerduty (PD) reported first-quarter fiscal 2026 earnings per share of $0.24, surpassing analyst estimates of $0.19 by $0.05, while revenue of $119.8 million slightly exceeded the consensus of $119.27 million. Despite this Q1 outperformance, the company's forward guidance presents a mixed outlook. For Q2 2026, Pagerduty anticipates EPS between $0.19 and $0.20, below the analyst consensus of $0.23, and Q2 revenue guidance of $122.50 million to $124.50 million brackets the consensus of $123.80 million, with the midpoint slightly trailing. Similarly, full-year 2026 revenue guidance of $493.00 million to $499.00 million falls short of the $503.30 million consensus. A positive note is the full-year 2026 EPS guidance of $0.95 to $1.00, which is above the $0.93 analyst consensus. This mixed forecast comes as PD's stock closed at $16.10, reflecting a decline of 9.14% over the last three months and 10.31% over the last twelve months. The sentiment is further clouded by 4 negative EPS revisions compared to 2 positive revisions in the past 90 days, and an InvestingPro financial health score of "fair performance".

Key Decisions for Investors

• Investors should carefully weigh Pagerduty's Q1 earnings beat and strong full-year EPS guidance against the weaker Q2 EPS and revenue guidance, and the below-consensus full-year revenue forecast.
• Given the stock's recent negative performance, the higher number of negative EPS revisions, and the "fair performance" financial health rating, a cautious stance is advisable, with close attention paid to upcoming earnings reports and any shifts in revenue trajectory.
• Consider the implications of the mixed guidance on future valuation, especially in light of the stock's -10.31% decline over the past year and the prevailing neutral to speculative market sentiment indicated by the provided signals.